Literature DB >> 18651548

Sex-based differences in lupus nephritis: a study of 235 Indian patients.

S S Soni1, S Gowrishankar, G K Adikey, A Raman.   

Abstract

BACKGROUND: This study was carried out to analyze clinical presentation, laboratory parameters and histology in lupus nephritis in males in comparison with females.
METHODS: Patients diagnosed with lupus nephritis between January 2001 and December 2005 were divided into 2 groups: males and females, and were analyzed with regard to clinical presentation, renal profile, serology and histology. All biopsies were reported by a single histopathologist as per WHO classification. Activity and chronicity indices were calculated. Comparison was made between the 2 groups. Statistical analysis was done using Strata version 6 software for Windows.
RESULTS: Of the 235 patients diagnosed to have lupus nephritis, 35 were males (14.9%) and 200 females (85.1%). Males were younger (mean age 23.22 +/- 9.32 years, range 9-44) compared with females (mean age 24.7 +/- 8.93 years, range 5-55). Extrarenal manifestations such as joint pains, alopecia, rash, fever, serous effusions and oral ulcers were comparable in both groups, as were hypertension (68.5% vs. 67%), nephrotic proteinuria (40% vs. 36%) and hematuria (80% vs. 73%). Renal dysfunction was significantly more common in males (60% vs. 37.5%, p<0.05) with higher levels of mean serum creatinine (2.67 vs. 1.62 mg/dL, p<0.05) and blood urea (63.25 vs. 48 mg/dL, p<0.01). Histologically, class IV lupus was the most common lesion in both groups (71.4% in males, 60% in females). Membranous lupus nephritis was more common in females (22% vs. 5.7%, p<0.05). Activity index (8.51 vs. 6.76, p<0.05) was higher in males.
CONCLUSIONS: Renal dysfunction and activity index are significantly higher in male patients with lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651548

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

1.  Male gender results in more severe lupus nephritis.

Authors:  Jozélio Freire de Carvalho; Ana Patrícia do Nascimento; Leonardo A Testagrossa; Rui Toledo Barros; Eloísa Bonfá
Journal:  Rheumatol Int       Date:  2009-09-27       Impact factor: 2.631

2.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.

Authors:  Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2013-03

3.  Good Long-Term Prognosis of Lupus Nephritis in the High-Income Afro-Caribbean Population of Martinique with Free Access to Healthcare.

Authors:  Benoit Suzon; Fabienne Louis-Sidney; Cédric Aglaé; Kim Henry; Cécile Bagoée; Sophie Wolff; Florence Moinet; Violaine Emal-Aglaé; Katlyne Polomat; Michel DeBandt; Christophe Deligny; Aymeric Couturier
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

4.  Risk factors for renal failure in patients with lupus nephritis: data from the spanish registry of glomerulonephritis.

Authors:  Carmen Vozmediano; Francisco Rivera; Juan Manuel López-Gómez; Domingo Hernández
Journal:  Nephron Extra       Date:  2012-10-10

5.  Clinical features, epidemiology, and short-term outcomes of proliferative lupus nephritis in Eastern India.

Authors:  D Sircar; G Sircar; R Waikhom; A Raychowdhury; R Pandey
Journal:  Indian J Nephrol       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.